Registration for PeproTech.com is no longer available. To order your PeproTech products online, register or logon to ThermoFisher.com.

Resources & Support

References

First Author
Saini, S
Title
MADD silencing enhances anti-tumor activity of TRAIL in anaplastic thyroid cancer.
Citation
Endocrine-Related Cancer;2019 6 1; 26(6) pg551-563
PubMed ID
Product Cited
Cross-Reactivity
Applications
Human
in vitro
Mouse
in vivo
First Author
Spano, C
Title
Soluble TRAIL Armed Human MSC As Gene Therapy For Pancreatic Cancer.
Citation
Scientific Reports; 2019 Feb 11; 9(1) pg1788
PubMed ID
Product Cited
Cross-Reactivity
Applications
Human
in vitro
Human
Western Blot
Mouse
in vivo
N/A
Western Blot
First Author
Fauster, A
Title
A cellular screen identifies ponatinib and pazopanib as inhibitors of necroptosis.
Citation
Cell death & disease; 2015 May 21; 6 pge1767
PubMed ID
Product Cited
Cross-Reactivity
Applications
Human
in vitro
Human
in vitro
Mouse
in vitro
Mouse
in vitro
First Author
Fu, L
Title
c-Jun NH2-terminal kinase-dependent upregulation of DR5 mediates cooperative induction of apoptosis by perifosine and TRAIL.
Citation
Molecular Cancer; 2010 Dec 20; 9 pg315
PubMed ID
Product Cited
Cross-Reactivity
Applications
Mouse
in vitro
Mouse
in vivo
First Author
Xu, J
Title
Activation of the Akt survival pathway contributes to TRAIL resistance in cancer cells.
Citation
PLoS ONE; 2010 Apr 19; 5(4) pge10226
PubMed ID
Product Cited
Cross-Reactivity
Applications
Human
in vitro
Mouse
in vitro
First Author
Hao, C
Title
TRAIL inhibits tumor growth but is nontoxic to human hepatocytes in chimeric mice.
Citation
Cancer Research; 2004 Dec 1; 64(23) pg8502-6
PubMed ID
Product Cited
Cross-Reactivity
Applications
First Author
Ehtesham, M
Title
Induction of glioblastoma apoptosis using neural stem cell-mediated delivery of tumor necrosis factor-related apoptosis-inducing ligand.
Citation
Cancer Research; 2002 Dec 15; 62(24) pg7170-4
PubMed ID
Product Cited
Cross-Reactivity
Applications
showing 7 of 7